Neurocrine Biosciences Inc - Feb 23, 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
10%+ Owner
Signature
/s/ Darin Lippoldt, Chief Legal Officer & Corporate Secretary
Stock symbol
VYGR
Transactions as of
Feb 23, 2023
Transactions value $
$39,032,821
Form type
4
Date filed
2/24/2023, 05:15 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Purchase $39M +4.4M +105.16% $8.88 8.58M Feb 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price was determined in accordance with that certain Stock Purchase Agreement dated January 8, 2023, between the reporting person and the issuer.